Stan Smith - Feb 24, 2025 Form 4/A - Amendment Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Stock symbol
MAIA
Transactions as of
Feb 24, 2025
Transactions value $
$168,500
Form type
4/A - Amendment
Date filed
3/5/2025, 04:39 PM
Date Of Original Report
Feb 25, 2025
Previous filing
Jan 3, 2025
Next filing
Mar 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $75K +50K +4.42% $1.50 1.18M Feb 24, 2025 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Warrants Purchase $93.5K +50K $1.87 50K Feb 24, 2025 Common Stock 50K $1.87 See Footnote F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025.
F2 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
F3 This Form 4/A is being filed to correct the "Date Exercisable" and "Expiration Date" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 3 to "February 24, 2025".
F4 These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on February 24, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the inital issuance date.
F5 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.